๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Are low-intensity induction strategies better for older patients with acute myeloid leukemia?

โœ Scribed by Gail J. Roboz; Usama Wissa; Ellen K. Ritchie; Usama Gergis; Sebastian Mayer; Joseph M. Scandura; Paul J. Christos; Eric J. Feldman

Book ID
113773643
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
532 KB
Volume
36
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Arsenic trioxide and low-dose cytarabine
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia
โœ Gail J. Roboz; Ellen K. Ritchie; Tania Curcio; Juliette Provenzano; Rebecca Carl ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 135 KB

## Abstract ## BACKGROUND. Acute myeloid leukemia (AML) carries a dismal prognosis in older patients. In this study, the authors evaluated the safety and efficacy of arsenic trioxide combined with lowโ€dose cytarabine in untreated patients aged โ‰ฅ60 years with AML. ## METHODS. In a phase 1/2 desig